Frontlight ResearchEarly access
Active, not recruitingNo phase
Acceptability of MBSR for People With HS
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 17 people enrolled
- Started
- 10 Aug 2026
- Expected to end
- 4 Feb 2027
- Type of study
- Interventional
- Treatments tested
- Mindfulness-Based Stress Reduction
- Record updated
- 3 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- At least 18 years of age
- Living with hidradenitis suppurativa (HS), diagnosed by a dermatologist
- Able to read, write, and speak English
- Access to a device with Internet access
Who cannot take part
- Lacks reliable access to the Internet or device (e.g., phone, tablet, laptop/computer) to participate in study activities
- Unable to confirm HS diagnosis by a dermatologist
Where in United States
- Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, United States
About the trial
What the trial wants to find out
Hidradenitis suppurativa (HS) is a chronic inflammatory condition that causes painful, recurring abscesses and nodules. It is associated with psychological stress and impaired quality of life. Our study aims to pilot a mindfulness-based stress reduction program tailored to patients with HS, then use their feedback to improve the program.
The group in the trial
- Intervention ArmTreatment being tested
Mindfulness-Based Stress Reduction
Treatment: Mindfulness-Based Stress Reduction
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pilot Single Arm Acceptability Study of Mindfulness-Based Stress Reduction for Individuals With Hidradenitis Suppurativa
- Record updated
- 3 November 2026